Impact of pharmacogenomics in achieving personalized/precision medicine in the clinical setting: a symposium report

The Indo-Swiss symposium on pharmacogenomic strategies for the implementation of personalized medicine was conducted as part of the Jawaharlal Institute of Postgraduate Medical Education and Research Integrated Pharmacogenomics Program in Puducherry, India, on 19 November 2022. The symposium was conducted in hybrid mode. The theme of symposium was the impact of pharmacogenomics on the achievement of personalized medicine/precision medicine in the clinical setting. The symposium sought to promote interaction among the participants to initiate future collaborative research projects. The symposium also served as a platform for young researchers to present their research findings as posters to the audience.

Automated summary

The Indo-Swiss symposium on pharmacogenomic strategies for the implementation of personalized medicine took place on November 19, 2022, as part of the Jawaharlal Institute of Postgraduate Medical Education and Research Integrated Pharmacogenomics Program in Puducherry, India. The symposium was conducted in a hybrid mode and focused on the impact of pharmacogenomics on achieving personalized medicine/precision medicine in the clinical setting. It aimed to promote interaction among participants for future collaborative research projects and provided a platform for young researchers to present their findings as posters to the audience.